VISION PARTNERS

1.FEATURE VIDEO
3.APPLICATION VIDEO
Test Rig
Negative Ions Benefits

In a continuing embodiment, C is also standing on the New York subway train where B has been openly smoking a marijuana cigarette. C sees several passengers putting on their anti-pathogenic glasses to keep from breathing in carcinogens from B’s marijuana cigarette. C also notices that the passengers who are wearing glasses mostly have the styles which have detachable elongated oval thrust cylinders.

Because C prefers the finer things in life, she removes a custom pair of A.F.E.C. sunglasses from her designer bag and places them on her face. C’s sunglasses are also equipped with an internal ionizer to help kill germs. Unlike the glasses worn by most of the passengers, the cylinders on each side of C’s glasses are not detachable and are integrated within the frame. Additionally, C’s frames are gun metal gray and made with light weight titanium alloy cylinders with gold trim and are fashioned to resemble two aerodynamic private jet engines.

*Medical/Covid-19 Disclaimer
At this time, Air Force-Field Eyewear Cylinders (A.F.E.C.) and its associated Air Force-Field Systems parent technology, to include: the INFANT-FORCE Product Line, has not been approved by the FDA or other medical sanctioning body to prevent, treat or reduce Covid-19, Influenza, or other airborne pathogens and/or contaminants. Statements, depictions and testing analysis contained within this website or publications are for informational purposes only and should not be considered medical advice. Questions relating to the prevention of the spread of Covid-19 or other airborne pathogens and contaminants should be referred to a licensed medical physician.
A PCT has been filed on this technology, permitting potential licensees to file multiple patent applications in the jurisdiction of members countries subscribing to Paris Cooperation Treaty. If your company would like to review the disclosure contained within the PCT, please indicate this on the contact form.

Coming Soon...